Skip to main content
. 2023 May 12;14:1084927. doi: 10.3389/fendo.2023.1084927

Table 3.

Singleton perinatal outcomes.

Variable GROUP P value
DOR N=29 NOR N=84 HOR N=86 D VS N D VS H N VS H
Age, y 32.72 ± 3.95 29.71 ± 2.65 29.33 ± 3.20
FSH, IU/L 8.14 ± 2.69 7.28 ± 1.58 6.88 ± 1.48
AFC 8.10 ± 5.13 9.56 ± 1.98 15.46 ± 4.66
AMH, ng/mL 2.59 ± 2.63 2.73 ± 0.90 7.67 ± 3.17
BMI, kg/m2 20.93 ± 2.52 21.61 ± 2.44 21.02 ± 2.18 ns ns ns
Type of endometriosis
endometriosis cysts 22(75.9%) 73(86.9%) 80(93.0%) ns ns ns
adenomyosis 6(20.7%) 10(11.9%) 4(4.7%) ns ns ns
cysts co-occurrence with adenomyosis 1(3.4%) 1(1.2%) 2(2.3%) ns ns ns
Gestational age, d 271.83 ± 8.89 270.46 ± 12.23 271.28 ± 9.44 ns ns ns
Birth weight, g 3356.55 ± 403.96 3281.67 ± 513.29 3283.20 ± 483.24 ns ns ns
Delivery mode
Natural labor 23(79.3%) 66(78.6%) 58(67.4%) ns ns ns
Cesarean delivery 6(20.7%) 18(21.4%) 28(32.6%) ns ns ns
Gender
Male 18(62.1%) 45(53.6%) 45(52.3%) ns ns ns
Female 11(37.9%) 39(46.4%) 41(47.7%) ns ns ns
Abnormal perinatal outcomes
Preterm birth < 37 week 2(6.9%) 9(10.7%) 9(10.5%) ns ns ns
Gestational hypertension 0 3(3.6%) 4(4.7%) ns ns ns
Gestational diabetes mellitus 7(24.1%) 6(7.1%) 5(5.8%) 0.039 0.015 ns
Placenta previa 4(13.8%) 8(9.5%) 5(5.8%) ns ns ns
Fetal malformation 0 0 4(4.7%) ns ns ns
Abruptio placentae 0 3(3.6%) 0 ns ns ns
Macrosomia > 4,000 g 2(6.9%) 3(3.6%) 4(4.7%) ns ns ns
Low birth weight < 2,500 g 0 7(8.3%) 4(4.7%) ns ns ns

Continuous data are reported as mean ± standard deviation. Categorical data are reported as n (%). One-way analysis of variance test was used for the continuous data, and chi-square test was used for categorical data. P<0.05 was considered statistically significant. ns, not statistically significant; DOR, diminished ovarian reserve; NOR, normal ovarian reserve; HOR, high ovarian reserve; AFC, antral follicle count, FSH, follicle stimulating hormone; AMH, anti-Müllerian hormone.